Green Cross Health Ltd · NZX:GXH
Green Cross Health — FY2026 Earnings Presentation
21 slides from Green Cross Health's earnings presentation, May 29, 2026
Slide 1: Annual Result for the Year to 31 March 2026
ANNUAL RESULT FOR THE YEAR TO 31 MARCH 2026
Slide 2: Disclaimer
Disclaimer The information in this presentation was prepared by Green Cross Health Limited (GXH) with due care and attention. However, the information is supplied in summary form and is therefore not necessarily complete, and no representation is made as to the accuracy, completeness or reliability
Slide 3: GXH Annual Result – Financial Overview
GXH Annual Result – Financial Overview Group Operating Profit Net Profit Pharmacy Medical Revenue (EBIT) After Tax Operating Profit Operating Profit (attributable to shareholders) $546.0m $45.3m $20.4m $22.2m $26.0m GXH Annual Results Presentation 29 May 2026 Pg 3 3
Slide 4: Pharmacy Division
Pharmacy Division Supporting easy access to quality health care GXH Annual Results Presentation 29 May 2026 Pg 4
Slide 5: Pharmacy Performance
Pharmacy Performance Pharmacy Operating Revenue ($m) 380.2 370.4 360.4 363.6 • Revenue up 2% to $380.2m driven by dispensing of high-value but low-margin FY23 FY24 FY25 FY26 drugs Pharmacy Operating Profit ($m) • Operating Profit up 4% to $22.2m • Total scripts in line with prior year on a same stor
Slide 6: Funding and Pharmacist Scope
Funding and Pharmacist Scope • Care & Advice Health Hubs are well positioned to deliver the Government’s proposed extension of pharmacy services for common health conditions to commence from 2 June 2026 • Opportunity remains for further expansion of pharmacists’ scope of practice under improved fund
Slide 7: Enhancing the Customer Experience
Enhancing the Customer Experience A new pharmacy app, which is integrated with the new online customer booking system, was launched to support the clinical services provided at the Care & Advice Health Hubs A shoppable Unichem website was introduced, allowing customers to browse stock availability o
Slide 8: Investment in Store Portfolio
Investment in Store Portfolio One greenfield pharmacy opened during the period, Unichem Mount Wellington in Auckland The Beauty by Life store concept expanded to two further locations in the period, Life Queensgate and Life Albany Investment in dispensary robotics, improving operational efficiency a
Slide 9: Pharmacy Future Focus
Pharmacy Future Focus Clinical Retail Customer Network scale Cost services disciplines experience & leadership focus Expand clinical Differentiated brands Utlising technology to Leveraging our Workforce services through Care and products with improve accessibility trusted brands & productivity, marg
Slide 10: Medical Division
Medical Division Growth, leadership and sustainable models of care GXH Annual Results Presentation 29 May 2026 Pg 10
Slide 11: Medical Performance
Medical Performance Medical Operating Revenue ($m) 140.3 153.4 165.8 133.2 Revenue up 8% to $165.8m driven by funding uplift and incentive payments FY23 FY24 FY25 FY26 linked to national immunisation targets Medical Operating Profit ($m) Operating Profit up 33% to $26.0m driven by top line growth an
Slide 12: Investment and Innovation
Investment and Innovation The Doctors website was refreshed to make enrolment and appointment booking simpler and more user friendly for patients The Doctors app registrations grew to 165,000 users, an increase of 45,000 (38%) since March 2025 The Doctors Online secured Government funding and double
Slide 13: Team Based Care
Team Based Care Doctors Nurse Practitioners Broader clinical team approach to patient care 385 GPs 27 nurse practitioners who 385 have the ability to diagnose, Improved access to appointments for patients 27 treat and prescribe with a variety of clinicians matched to their medication for a specified
Slide 14: Community Care
Community Care GP clinics – currently funded by 12 PHOs GP clinics Health New Zealand approved the Group to establish a new Primary Health Organisation (PHO), Community Care Limited, to commence operations from 1 July 2026 Significant milestone allowing direct funding to the network, with 54 practic
Slide 15: Medical Future Focus
Medical Future Focus Innovative Community Technology Operations Cost care model Care improvement & margin High quality patient Collaborating with Utilising data and Continuous Workforce care delivered Health New Zealand systems to increase improvement in productivity & through a team- to improve pat
Slide 16: Group Financial Result
Group Financial 12 months ended 31 March 2026 Result GXH Annual Results Presentation 29 May 2026 Pg 16
Slide 17: Group Revenue and Operating Profit
Group Revenue and Operating Profit GXH Operating Revenue ($m) GXH Operating Profit ($m) 546.0 45.3 523.8 34.3 38.7 31.8 503.9 493.6 FY23 FY24 FY25 FY26 FY23 FY24 FY25 FY26 • Revenue up 4% to $546.0m • Operating Profit of $45.3m • FY26 Revenue increase due to improved • Operating Profit increase driv
Slide 18: Group NPAT, EPS & Dividend
Group NPAT, EPS & Dividend GXH NPAT Attributable to Shareholders ($m) Dividends Per Share (cps) 34.00 * 28.00 20.4 15.0 16.0 12.0 7.00 6.00 4.50 5.75 FY23 FY24 FY25 FY26 FY23 FY24 FY25 FY26 Based on dividends paid during the financial year *Special dividend paid following the divestment of Community
Slide 19: Working Capital and Operating Cashflow
Working Capital and Operating Cashflow GXH Gearing Ratio (debt / debt + equity) GXH Operating Cash Flow ($m) 17.3% 52.6 54.6 10.4% 11.9% 9.4% 45.9 46.0 FY23 FY24 FY25 FY26 FY23 FY24 FY25 FY26 • Gearing ratio of 9.4% as at 31 March 2026 • Operating Cash Flow of $54.6m • Undrawn committed debt facilit
Slide 20: About us
About us GXH Annual Results Presentation 29 May 2026 Pg 20
Slide 21: Who we are
Who we are GXH Annual Results Presentation 29 May 2026 Pg 21